| Bacteria | Features | References |
| ATCC 25923 | Reference strain | ā | S. aureus MSSA1 | Clinical isolate: Met susceptible; Nisr, Chlr | [8, 9] | S. aureus MRSA3 | Clinical isolate: Ofxar, Kanr, Tetr, Ermr | [8] | S. aureus MRSA4 | Clinical isolate: Ofxar, Kanr, Cypr, Chlr, Genr, Nisr, Ampr | [8, 9] | S. aureus MRSA6 | Clinical isolate: Ofxar, Flxr, Kanr, Tetr, Cypr, IM/Csr, Chlr, Genr, Nisr, Ampr | [8, 9] | S. aureus MRSA8 | Clinical isolate: Ofxar, Flxr, Kanr, Ermr, Cypr, Im/Csr, Chlr, Genr, Nisr, Ampr | [8, 9] | S. aureus MRSA9 | Clinical isolate: Ofxar, Flxr, Tetr, Ermr, Cypr, Im/Csr, Chlr, Genr, Nisr, Ampr | [8, 9] | S. aureus MRSA11 | Clinical isolate: Ofxar, Kanr, Ermr, Cypr, Im/Csr, Chlr, Nisr, Ampr | [8, 9] | S. aureus MRSA12 | Clinical isolate: Ofxar, Flxr, Kanr, Ermr, Im/Csr, Chlr, Genr, Nisr, Ampr | [8, 9] | SA01 | Clinical isolate: Ermr, Ampr | [54] | SA07 | Clinical isolate: Ermr, Doxr | [54] | SA18 | Clinical isolate: Ampr, Doxr, Vmr | [54] | SA23 | Clinical isolate: Imir, Augr | [54] | SA36 | Clinical isolate: Doxr, Vmr | [54] | SA39 | Clinical isolate: Ampr | [54] | SA56 | Clinical isolate: Ampr, Doxr | [54] | SA64 | Clinical isolate: Ampr, Doxr | [54] | SA68 | Clinical isolate: Ampr, Vmr | [54] | SA88 | Clinical isolate: Ermr, Vmr | [54] | SA114 | Clinical isolate: Ampr, Doxr | [54] | SA116 | Clinical isolate: Ermr | [54] | SA124 | Clinical isolate: Ermr | [54] | SA126 | Clinical isolate: Ampr, Doxr | [54] | SA127 | Clinical isolate: Ampr, Doxr | [54] | SA135 | Clinical isolate: Ermr | [54] | SA139 | Clinical isolate: Ermr | [54] |
|
|
Chlr, Cypr, Ermr, Flxr, Im/Csr, Kanr, Metr, Ofxar, Tetr, Vmr, Ampr, Doxr, Augr, Genr, and Nisr resistance to chloramphenicol, ciprofloxacin, erythromycin, flomoxef, imipenem/cilastatin sodium, kanamycin, methicillin, ofloxacin, tetracycline, vancomycin, ampicillin, doxycycline, augmentin, gentamicin, and nisin, respectively, SA: Staphylococcus aureus.
|